6iw7
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='6iw7' size='340' side='right'caption='[[6iw7]], [[Resolution|resolution]] 2.69Å' scene=''> | <StructureSection load='6iw7' size='340' side='right'caption='[[6iw7]], [[Resolution|resolution]] 2.69Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[6iw7]] is a | + | <table><tr><td colspan='2'>[[6iw7]] is a 28 chain structure with sequence from [https://en.wikipedia.org/wiki/Mycobacterium_tuberculosis_CDC1551 Mycobacterium tuberculosis CDC1551] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6IW7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6IW7 FirstGlance]. <br> |
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.692121Å</td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.692121Å</td></tr> | ||
| - | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=AV3:4-[(4- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=AV3:4-[(4-fluoranyl-2-methyl-3~{H}-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline'>AV3</scene>, <scene name='pdbligand=BEZ:BENZOIC+ACID'>BEZ</scene></td></tr> |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6iw7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6iw7 OCA], [https://pdbe.org/6iw7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6iw7 RCSB], [https://www.ebi.ac.uk/pdbsum/6iw7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6iw7 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6iw7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6iw7 OCA], [https://pdbe.org/6iw7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6iw7 RCSB], [https://www.ebi.ac.uk/pdbsum/6iw7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6iw7 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| Line 16: | Line 16: | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Mycobacterium tuberculosis CDC1551]] | [[Category: Mycobacterium tuberculosis CDC1551]] | ||
| + | [[Category: Synthetic construct]] | ||
[[Category: Bao R]] | [[Category: Bao R]] | ||
[[Category: Luo YF]] | [[Category: Luo YF]] | ||
Revision as of 04:06, 5 October 2024
structural insights into Mycobacterium tuberculosis ClpP1P2 inhibition by Cediranib: implications for developing antimicrobial agents targeting Clp protease
| |||||||||||
